Norges Bank
CPIX icon

Norges Bank’s Cumberland Pharmaceuticals CPIX Stock Holding History

Norges Bank’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-18,734
Closed -$108K – 2238
2015
Q3 		$108K Hold
18,734
– – ﹤0.01% 2254
2015
Q2 		$134K Hold
18,734
– – ﹤0.01% 2240
2015
Q1 		$125K Sell
18,734
-3,666
-16% -$22.9K ﹤0.01% 2256
2014
Q4 		$134K Hold
22,400
– – ﹤0.01% 2314
2014
Q3 		$111K Sell
22,400
-22,400
-50% -$108K ﹤0.01% 2304
2014
Q2 		$202K Buy
44,800
+22,400
+100% +$100K ﹤0.01% 2227
2014
Q1 		$101K Hold
22,400
– – ﹤0.01% 2104
2013
Q4 		$114K Buy
+22,400
New +$109K ﹤0.01% 2087

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank's CPIX Position: Q4 2015 in Review

Norges Bank sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2015, closing a stake of 18,734 shares — an estimated $108K sold.

Norges Bank first reported a position in CPIX in Q4 2013 and held it in 8 quarters. The position peaked at $202K in Q2 2014. 47 funds tracked by Wall St. Rank hold CPIX as of Q4 2015.

  • Norges Bank reported no remaining Cumberland Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Norges Bank sold 18,734 Cumberland Pharmaceuticals shares in Q4 2015, an estimated $108K.
  • Norges Bank first reported a position in Cumberland Pharmaceuticals in Q4 2013 and held it in 8 quarters.
  • Norges Bank's Cumberland Pharmaceuticals position peaked at $202K in Q2 2014.
  • 47 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2015.

Based on Norges Bank's 13F filing for Q4 2015, filed 10 Feb 2016.